N-[2-(4-methylpiperidin-1-yl)ethyl]propan-2-amine, 95.0%, 1g

1-(3-fluorobenzoyl)-2-methylpiperazine, 95.0%, 2g

2-(4-Methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

5-CHLORO-6-FLUOROPYRIDIN-3-YLBORONIC ACID, 92.0%, 1g

5-Nitro-4(3H)-quinazolinone, ��97.0%, 100mg

2-(2-fluorophenoxy)ethanesulfonyl chloride, 95.0%, 1g

N-methyl-1-(4-pyridinyl)ethanamine ethanedioate, 95.0%, 5g

1-(4-methoxyphenyl)-2-(3-nitro-1H-pyrazol-1-yl)ethan-1-one, 95.0%, 2g

4-piperazin-1-ylquinazoline, 95.0%, 250mg

3-(bromomethyl)-1,2,4-oxadiazole, 95.0%, 250mg

Ethyl 2-(5-chloro-2-methoxyphenyl)acetate, 96%, 1g

tert-butyl methyl ether, min. 99.5%, for synthesis, 1 l, glass packaging

Myristoyl Chloride>98.0%(GC)(T)400g